课题基金 / 基金详情

Mechanisms through which ShcA integrates tyrosine kinase signaling to promote breast cancer progression

Mechanisms through which ShcA integrates tyrosine kinase signaling to promote breast cancer progression
ShcA 整合酪氨酸激酶信号传导促进乳腺癌进展的机制
批准号：
209922
负责人：
Ursini-Siegel Giuseppina
金额：
$49.64万
依托单位：
Lady Davis Institute for Medical Research (Mtl)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2010
资助国家：
加拿大
项目状态：
已结题
起止时间：
2010-09-01 至 2015-09-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=209922&lang=en
关键词：
Angiogenesis Breast Cancer Erbb2 Receptor Tyrosine Kinase Shca Signal Transduction Transgenic Mice Tumor Stroma

项目摘要

项目成果

Ursini-Siegel Giuseppina的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Breast cancer remains the most prevalent cancer in Canadian women and the second leading cause of cancer-related deaths in this group. While targeted therapies have contributed to a decreased incidence of breast cancer mortality, the prevalence of this di
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Inducing oxidative stress as a mechanism to increase the clinical impact of complex I inhibitors in treating aggressive breast cancers.
Capitalizing on an oxidative stress response to sensitize poor outcome cancers to PARP inhibitors
Understanding how oxidative stress influences tumor evolution via metabolic reprogramming
Defining the mechanisms and therapeutic potential of ShcA-mediated angiogenesis and metabolism that fuel breast tumorigenesis
海外基金